North American Report

Cholestatic Pruritus: Market Insights And Market Forecast

 Breaking News
  • No posts were found

Cholestatic Pruritus: Market Insights And Market Forecast

May 25
21:58 2021
Cholestatic Pruritus: Market Insights And Market Forecast

DelveInsight has launched a new report on Cholestatic Pruritus Market

 

Cholestasis is defined as a decrease in bile flow due to the impaired secretion by hepatocytes or due to the obstruction of bile flow through intra-or extra-hepatic bile ducts. This impairment in bile secretion occurs at somewhere between the liver cells (which produce bile) and the duodenum (the first segment of the small intestine).

 

Request for free sample copy– https://www.delveinsight.com/sample-request/cholestatic-pruritus-market

 

The key players elaborated in the Cholestatic Pruritus Market includes Cymabay Therapeutics, Albireo Pharma, GlaxoSmithKline, Mirum Pharmaceuticals, and Care Pharmaceuticals

 

Furthermore, Pruritus is a distressing manifestation of both intrahepatic cholestasis and extrahepatic biliary obstruction. Intrahepatic cholestasis processes associated with pruritus include Primary Biliary Cirrhosis (PBC), and cholestasis of pregnancy (pruritus gravidarum), drug-induced cholestasis, and viral hepatitis. However, pruritus is also seen in extrahepatic cholestatic liver diseases such as primary sclerosing cholangitis (PSC), and cancer of the head of the pancreas.

Historically, pruritus has been observed to accompany jaundice, but it is not uncommon to see pruritus as the first manifestation of cholestasis even before the onset of jaundice or other symptoms. There is considerable variation in the frequency and prevalence of pruritus in different cholestatic conditions.

 

Cholestatic Pruritus Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

 

Cholestatic Pruritus Key Companies

  • Cymabay Therapeutics,
  • Albireo Pharma,
  • GlaxoSmithKline,
  • Mirum Pharmaceuticals,and
  • Care Pharmaceuticals

 

Cholestatic Pruritus Key Strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Epidemiology Segmentation
  • Drugs Uptake
  • Highly Analyzed Market
  • Key Cross Competition
  • Market Size by Country
  • Market Size by Therapy

 

Cholestatic Pruritus Treatment Market

The treatment of cholestatic pruritus is limited by the availability of only four classes of drugs that are recommended by guidelines and for which there is strong evidence. However, these therapeutic regimens have poor side-effect profiles and need regular monitoring for adverse events (mainly for hepatotoxicity). Moreover, treatment remains extremely difficult and challenging in those patients who pose symptoms despite the prescription of various combination therapies. Therefore, there is an unmet need for safer and effective therapies to treat pruritus in cholestasis.

 

Table of content

  1. Key Insights
  2. Executive Summary of Cholestatic Pruritus
  3. Competitive Intelligence Analysis for Cholestatic Pruritus
  4. Cholestatic Pruritus Market Overview at a Glance
  5. Cholestatic Pruritus : Disease Background and Overview
  6. Patient Journey
  7. Cholestatic Pruritus Epidemiology and Patient Population
  8. Treatment Algorithm, Current Treatment, and Medical Practices
  9. Unmet Needs
  10. Key Endpoints of Cholestatic Pruritus Treatment
  11. Marketed Products
  12. Emerging Therapies
  13. Cholestatic Pruritus : Seven Major Market Analysis
  14. Attribute analysis
  15. 7MM: Market Outlook
  16. Access and Reimbursement Overview of Cholestatic Pruritus
  17. KOL Views
  18. Market Drivers
  19. Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer
  23. About DelveInsight

 

Enquire about Cholestatic Pruritus Market Report– https://www.delveinsight.com/sample-request/cholestatic-pruritus-market

 

About Us

DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical, Bio-Tech and Medical devices companies formulate prudent business decisions for improving their performances to stay ahead of the competitors.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/